Bristol Myers Squibb names EVP

Elizabeth Mily has been named EVP strategy and business development at Bristol Myers Squibb. Previously, Mily was managing director and chair of the global life sciences group in the global healthcare unit at Barclays.

Ashfield names quality, compliance head

Carey Galvin has been appointed global head of quality and compliance for Ashfield Commercial, Patient Solutions and Medical Affairs. Galvin has been with Ashfield since 2016, most recently as VP of quality and compliance for North America.

Eversana names digital health lead

Ed Cox has been appointed EVP of strategic alliances and global head of Eversana’s new digital medicine practice. Cox joins the company from Dthera Sciences, where he served as CEO.

RubrYc Therapeutics names chief science officer

Ramesh Baliga has joined RubrYc Therapeutics, a pre-clinical company developing therapies for cancer and autoimmune disease, as chief science officer. Previously, Baliga was at IGM Biosciences and founded Extend Biopharma.

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at